• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.202 -0.158 (-2.95%)
Streaming Delayed Price Updated: 1:54 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 783,765
Open 5.370
Bid (Size) 5.200 (2,100)
Ask (Size) 5.210 (1,700)
Prev. Close 5.360
Today's Range 5.185 - 5.370
52wk Range 3.933 - 7.540
Shares Outstanding 54,191,361
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 31, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
December 15, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire

Performance

YTD
-2.0%
-2.0%
1 Month
-1.8%
-1.8%
3 Month
-4.0%
-4.0%
6 Month
-21.8%
-21.8%
1 Year
+1.2%
+1.2%

More News

Read More
News headline image
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
December 11, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Via Benzinga
News headline image
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
December 08, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
November 12, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
November 12, 2025
Via Benzinga
News headline image
Here's Why Abeona Therapeutics Popped Higher Today ↗
November 12, 2025
Via The Motley Fool
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
November 12, 2025
Via Chartmill
News headline image
Abeona Therapeutics (NASDAQ:ABEO) Stock Falls on Revenue Miss Despite Q3 EPS Beat ↗
November 12, 2025
Via Chartmill
News headline image
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
November 12, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
What to Expect from Abeona Therapeutics's Earnings ↗
November 11, 2025
Via Benzinga
News headline image
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
November 07, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
October 30, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
October 20, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
October 13, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
October 08, 2025
From Abeona Therapeutics Inc.; Children's Hospital of Colorado
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 16, 2025
Via Benzinga
News headline image
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
August 29, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Posts Q2 Profit on Asset Sale ↗
August 14, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
August 14, 2025
From Abeona Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Abeona Therapeutics Inc. - Common Stock publicly traded?
Yes, Abeona Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Abeona Therapeutics Inc. - Common Stock trade on?
Abeona Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Abeona Therapeutics Inc. - Common Stock?
The ticker symbol for Abeona Therapeutics Inc. - Common Stock is ABEO on the Nasdaq Stock Market
What is the current price of Abeona Therapeutics Inc. - Common Stock?
The current price of Abeona Therapeutics Inc. - Common Stock is 5.202
When was Abeona Therapeutics Inc. - Common Stock last traded?
The last trade of Abeona Therapeutics Inc. - Common Stock was at 01/23/26 01:54 PM ET
What is the market capitalization of Abeona Therapeutics Inc. - Common Stock?
The market capitalization of Abeona Therapeutics Inc. - Common Stock is 281.90M
How many shares of Abeona Therapeutics Inc. - Common Stock are outstanding?
Abeona Therapeutics Inc. - Common Stock has 282M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap